0001093557-16-000694.txt : 20160913
0001093557-16-000694.hdr.sgml : 20160913
20160913203211
ACCESSION NUMBER: 0001093557-16-000694
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160909
FILED AS OF DATE: 20160913
DATE AS OF CHANGE: 20160913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LISTER JOHN
CENTRAL INDEX KEY: 0001464741
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 161883993
MAIL ADDRESS:
STREET 1: C/O DEXCOM, INC
STREET 2: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-09-09
0
0001093557
DEXCOM INC
DXCM
0001464741
LISTER JOHN
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
0
1
0
0
General Manager, EMEA
Common Stock
2016-09-09
4
S
0
3560.0
93.6493
D
87214
D
Common Stock
2016-09-09
4
D
0
6114.0
93.7227
D
81100
D
Common Stock
2016-09-09
4
D
0
3525.0
93.7227
D
77575
D
On November 12, 2015, Mr. Lister adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Lister. The shares set forth above were sold pursuant to the 10b5-1 Plan.
This transaction was executed in multiple trades at prices ranging from $92.86 to $94.57. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Included in this number are 61,584 unvested restricted stock units, 32,000 of which were grant on June 30, 2016 and shall vest through March 8, 2019, 18,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 10,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017.
These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
CONFIRMING STATEMENT: This Statement confirms that the undersigned John Lister, has authorized and designated Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of DexCom, Inc. The authority of Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of DexCom, Inc., unless earlier revoked in writing. The undersigned acknowledges that Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. Date: August 25, 2016 /s/ JOHN LISTER John Lister
By: Kevin Sun For: John D. Lister
2016-09-13